Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Shares Issued (2023 - 2025)

Kura Oncology (KURA) has disclosed Shares Issued for 3 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 40.64% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 79.16% decrease, with the full-year FY2025 number at $1.8 million, down 79.16% from a year prior.
  • Shares Issued was $1.1 million for Q4 2025 at Kura Oncology, up from $515000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $3.0 million in Q2 2024 to a low of $84000.0 in Q3 2023.
  • A 3-year average of $1.2 million and a median of $807000.0 in 2024 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: skyrocketed 2521.43% in 2024, then tumbled 94.4% in 2025.
  • Kura Oncology's Shares Issued stood at $691000.0 in 2023, then grew by 16.79% to $807000.0 in 2024, then skyrocketed by 40.64% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Shares Issued are $1.1 million (Q4 2025), $515000.0 (Q2 2025), and $143000.0 (Q1 2025).